Biosketch / Results /

Michael Bogenschutz

Professor, Department of Psychiatry

Contact Info

646/501-4026


It's time to take psilocybin seriously as a possible treatment for substance use disorders
Bogenschutz, Michael P. It's time to take psilocybin seriously as a possible treatment for substance use disorders. American journal of drug & alcohol abuse. 2016 Aug 24;:1-3 (2221592)

Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study
Bogenschutz, Michael P; Bhatt, Snehal; Bohan, Juliane; Foster, Bellelizabeth; Romo, Paul; Wilcox, Claire E; Tonigan, J Scott. Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study. American journal of drug & alcohol abuse. 2016 May 16;:1-10 (2112122)

The efficacy of attention bias modification therapy in cocaine use disorders
Mayer, Andrew R; Wilcox, Claire E; Dodd, Andrew B; Klimaj, Stefan D; Dekonenko, Charlene J; Claus, Eric D; Bogenschutz, Michael. The efficacy of attention bias modification therapy in cocaine use disorders. American journal of drug & alcohol abuse. 2016 May 16;42(4):459-468 (2112112)

Hair analysis and its concordance with self-report for drug users presenting in emergency department
Sharma, Gaurav; Oden, Neal; VanVeldhuisen, Paul C; Bogenschutz, Michael P. Hair analysis and its concordance with self-report for drug users presenting in emergency department. Drug & alcohol dependence. 2016 Aug 7;167:149-155 (2219222)

Outpatient treatment of alcohol use disorders among subjects 60+ years: design of a randomized clinical trial conducted in three countries (Elderly Study)
Andersen, Kjeld; Bogenschutz, Michael P; Buhringer, Gerhard; Behrendt, Silke; Bilberg, Randi; Braun, Barbara; Ekstrom, Claus Thorn; Forcehimes, Alyssa; Lizarraga, Christine; Moyers, Theresa B; Nielsen, Anette Sogaard. Outpatient treatment of alcohol use disorders among subjects 60+ years: design of a randomized clinical trial conducted in three countries (Elderly Study). BMC psychiatry. 2015 Nov 14;15:280-280 (1856192)